People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Quincy Bioscience Holding Co Inc | — | Pharmaceuticals | Series A | $5.2M | $160.5M | 2009 |
| Quincy Animal Health Llc | — | Pharmaceuticals | Seed | $3.0M | $5.0M | — |
Mark Y. Underwood at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Y. Underwood on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael J. Beaman | 2 | 2 |
| Robert Y. Flemming | 1 | 1 |
| Robert C. Risch, Jr. | 1 | 1 |
| Robert Y. Moser | 1 | 1 |
| John Y. Dedrick | 1 | 1 |
| David Y. Merrick | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.